Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Korean Postmenopausal Women With Osteoporosis
NCT01457950Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2011
- Primary completion
- Dec 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in postmenopausal osteoporosis, sponsored by GSK. Started Nov 2011; status: completed.
02
Drugs
denosumab
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01457950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01457950.